Making a noteworthy insider sell on September 29, Solas Capital Management LLC, 10% Owner at Epsilon Energy (NASDAQ:EPSN), is reported in the latest SEC filing. What Happened: According to a …
Tag:
sold
-
-
Cosentyx, an autoimmune disease therapy that cost the healthcare industry $7.7 billion in 2024, will be offered at a 55% discount beginning in November. The drug’s manufacturer, Novartis, said Sept. …